Abbott Laboratories
ABT
#74
Rank
NZ$378.47 B
Marketcap
NZ$217.46
Share price
0.09%
Change (1 day)
11.41%
Change (1 year)
Categories

Abbott Laboratories (ABT), (founding name: Abbott Alkaloid Company) is a global pharmaceutical company with around 73,000 employees in 150 countries. Abbott was founded in 1888 by Wallace C. Abbott (1857-1921) and is headquartered in Abbott Park, a northern suburb of Chicago, Illinois.

Abbott Laboratories (ABT) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : NZ$57.08 Billion

According to Abbott Laboratories's latest financial reports the company's total liabilities are NZ$57.08 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Abbott Laboratories - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31NZ$59.42 B9.28%
2023-12-31NZ$54.37 B-8.02%
2022-12-31NZ$59.11 B3.08%
2021-12-31NZ$57.34 B4.64%
2020-12-31NZ$54.80 B0.89%
2019-12-31NZ$54.32 B-0.03%
2018-12-31NZ$54.34 B-14.52%
2017-12-31NZ$63.57 B37.84%
2016-12-31NZ$46.12 B58.46%
2015-12-31NZ$29.10 B16.54%
2014-12-31NZ$24.97 B16.04%
2013-12-31NZ$21.52 B-56.2%
2012-12-31NZ$49.13 B7.27%
2011-12-31NZ$45.80 B-6.53%
2010-12-31NZ$49.00 B20.59%
2009-12-31NZ$40.64 B-5.29%
2008-12-31NZ$42.90 B49.84%
2007-12-31NZ$28.63 B-8.81%
2006-12-31NZ$31.40 B45.76%
2005-12-31NZ$21.54 B6.45%
2004-12-31NZ$20.23 B1.46%
2003-12-31NZ$19.94 B-23.21%
2002-12-31NZ$25.97 B-24.24%
2001-12-31NZ$34.28 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
NZ$196.88 B 244.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$200.52 B 251.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
NZ$89.94 B 57.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
NZ$6.87 B-87.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$74.28 B 30.14%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Bristol-Myers Squibb
BMY
NZ$135.76 B 137.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
NZ$33.08 B-42.05%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$118.75 B 108.05%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
NZ$108.44 B 89.98%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
GlaxoSmithKline
GSK
NZ$106.27 B 86.18%๐Ÿ‡ฌ๐Ÿ‡ง UK